Aurora Cannabis (TSX:ACB) remains unprofitable, but has managed to reduce its losses at an impressive rate of 61.2% per year ...
Aurora Cannabis (ACB) is expected to post earnings of -$0.07 during its second quarter earnings on November 5, before the opening bell. Analysts expect the Alberta-based firm to report a revenue of ...
Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.
TipRanks on MSN
Aurora Cannabis Achieves Record Revenue in Q2 2026
Aurora Cannabis ( ($TSE:ACB) ) has shared an announcement. Aurora Cannabis reported its fiscal 2026 second quarter results, showcasing a 15% ...
Looking ahead, Aurora expects its third-quarter 2026 consolidated revenue to increase year over year, led by 8% to 12% growth in global medical cannabis sales. Management also projects continued ...
Shares of Aurora Cannabis Inc. ACB slid 6.97% to $4.54 Tuesday, on what proved to be an all-around poor trading session for ...
Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - ...
EDMONTON, AB, Sept. 9, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announced the launch of the English-language ...
Aurora Cannabis Inc on Tuesday named Miguel Martin its chief executive officer, tasking the insider to turn around the ...
Canadian pot producer Aurora Cannabis Inc , on Tuesday forecast first-quarter revenue below analysts' estimates, sending its U.S-listed shares tumbling 15%.
An Aurora man is facing drug charges after police say firefighters found a large cannabis-growing operation in his home while they were investigating a fire. Ryan Prey, 32, of the 1800 block of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results